|
⚲
|
| Keyboard |
| Krebs Andreas
✚
|
|
|---|---|
| CIK # | 0001438946 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001438946] | |
| 4 | [0001438946] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Krebs Andreas | |
| Definium Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Definium Therapeutics Inc MNMD
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 75,187 | $0.00 | |
|
Definium Therapeutics Inc MNMD
Stock Option (Right to Buy) · derivative
|
2024-06-10 | Grant | 16,506 | $0.00 | |
|
Definium Therapeutics Inc MNMD
Stock Option (Right to Buy) · derivative
|
2023-06-21 | Grant | 19,203 | $0.00 | |
|
Definium Therapeutics Inc MNMD
Common Shares
|
2023-06-21 | Grant | 13,671 | $0.00 | |
|
Definium Therapeutics Inc MNMD
Director's Deferred Share Units · derivative
|
2022-06-01 | Grant | 98,198 | ||
|
Definium Therapeutics Inc MNMD
Stock Option (Right to Buy) · derivative
|
2022-06-01 | Grant | 133,744 | $0.00 | |
|
Definium Therapeutics Inc MNMD
Subordinate Voting Shares
|
2022-06-01 | Grant | 21,552 | $0.00 | |
|
Definium Therapeutics Inc MNMD
Director's Deferred Share Units · derivative
|
2022-06-01 | Grant | 28,628 | ||
|
Definium Therapeutics Inc MNMD
Director's Deferred Share Units · derivative
|
2022-06-01 | Grant | 717,937 |